FASN and melanoma: The inhibition of FASN with the compound orlistate impairs melanoma-induced metastases and angiogenesis in mice [142], and the silencing of FASN attenuates CD44 expression-induced signaling and metastasis formation in colorectal cancer mouse models [143].